knowledge -WSS

knowledge

author：entertainment 2025-09-28 00:53:49 - browse：742

PHILADELPHIA — Novo Nordisk, which has dominated the diabetes and obesity markets with its blockbuster drugs Ozempic and Wegovy, now also wants to be a major player in heart disease.

The landmark Select trial presented over the weekend — which showed Wegovy significantly cut the risk of heart complications — is just one of many efforts by the Danish drugmaker to expand into the cardiovascular space. It’s also developing several treatments specific to heart disease and is acquiring a medication for high blood pressure.

“We have a clear vision of being an established cardiovascular company, just as we see ourselves as leaders in diabetes and obesity,” Martin Lange, Novo’s executive vice president of development, said in an interview here at the American Heart Association conference.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： DeSantis can now import cheaper drugs. But will Biden get credit?

hotspot

leisure time

WSS

Heart disease and mental health: A look at cardiac psychology

JPM 2024: FogPharma’s CEO unveils ‘contrarian’ plan in oncology

Pentagon will tighten controls on classified information after Discord leak

Three issues to watch in global health in 2024

Heart disease and mental health: A look at cardiac psychology

China dismisses criticism of top diplomat's comments appearing to push for race

knowledge

knowledge

focus

The high cost of giving birth even with insurance

A bus careens into a gulch in southern Mexico, leaving 27 people dead

DIEP, the 'gold standard' of breast reconstruction, is under threat

New Medicare drug pricing powers could soon be upended in court

In age of alternative facts, a scholarly course on calling out crap

Readout LOUD podcast: live from JPM 2024

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

China dismisses criticism of top diplomat's comments appearing to push for race

ChatGPT in medicine: STAT answers readers' burning questions

DeSantis can now import cheaper drugs. But will Biden get credit?

explore

Readout LOUD podcast: 2023 in review, and a look at biotech in 2024

Dramatic video released of Russian fighter jets 'harassing' US drones over Syria

Former New York Mayor de Blasio and wife announce separation, but not divorce

The SUPPORT Act is critical to fighting the opioid crisis

The nurse manager staffing crisis is hurting patients

Generative AI mines health records to identify patients’ social needs

hotspot

leisure time

entertainment

entertainment